{{NoteTA|G1=Lifesciences}}
{{PBB|geneid=5551}}
'''穿孔素'''（[[法文/英文|法文/英文]]：'''Perforin'''）是人體內一類由''PRF1''[[基因|基因]]编码的[[蛋白質|蛋白質]]<ref name="pmid1505959">{{cite journal |author= Fink TM, Zimmer M, Weitz S, Tschopp J, Jenne DE, Lichter P |title= Human perforin (PRF1) maps to 10q22, a region that is syntenic with mouse chromosome 10 |journal= Genomics |volume= 13 |issue= 4 |pages= 1300–2 |date=Sep 1992 |pmid= 1505959 |pmc= |doi =10.1016/0888-7543(92)90050-3 }}</ref><ref name="pmid2592021">{{cite journal |author= Shinkai Y, Yoshida MC, Maeda K, Kobata T, Maruyama K, Yodoi J, Yagita H, Okumura K |title= Molecular cloning and chromosomal assignment of a human perforin (PFP) gene |journal= Immunogenetics |volume= 30 |issue= 6 |pages= 452–7 |date=Jan 1990 |pmid= 2592021 |pmc= |doi =10.1007/BF02421177 }}</ref><ref name="entrez">{{cite web |title= Entrez Gene: PRF1 perforin 1 (pore forming protein)| url= http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5551| accessdate= }}</ref>。

==功能==
穿孔素是一種由[[细胞毒性T细胞|细胞毒性T细胞]]或[[自然殺傷細胞|自然殺傷細胞]]分泌的{{link-en|細胞溶解|Cytolysis}}蛋白質。它們會插入靶細胞的細胞膜中，並形成孔隙。穿孔素的{{link-en|MACPF|MACPF}}域能夠促使細胞溶解<ref>{{cite journal |author=Tschopp J, Masson D, Stanley KK |title=Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis |journal=Nature |volume=322 |issue=6082 |pages=831–4 |year=1986 |pmid=2427956 |doi=10.1038/322831a0}}</ref>。該域與[[革蘭氏陽性菌|革蘭氏陽性菌]]的膽固醇依賴性[[溶細胞素|溶細胞素]]有一定的同源型<ref name="macpfstructure"/>。

穿孔素在結構上和功能上與[[補體成分9|補體成分9]]（C9）具有一些共同點。比如說，穿孔素可以像補體成分9那樣在細胞膜上形成能夠非特異性地裂解多種靶細胞的孔洞。穿孔素是促細胞溶解顆粒中的一種主要促細胞裂解蛋白，在由T細胞和天然殺傷細胞介導的細胞溶解中起關鍵作用<ref name="entrez"/>。它通過在細胞膜上產生孔洞，從而讓鈣離子大量流入細胞，使得靶細胞啓動細胞膜的修復機制。上述的修復機制可讓穿孔素和顆粒酶進入早期內涵體<ref name="pmid21685908">{{cite journal |author= Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, Goping IS, Bleackley RC, Kirchhausen T, Lieberman J |title= Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells |journal= Nat. Immunol. |volume= 12 |issue= 8 |pages= 770–7 |year= 2011 |pmid= 21685908 |pmc= 3140544 |doi= 10.1038/ni.2050 }}</ref>。

==臨床意義==
有缺陷的''PRF1''等位基因純合會導致2型{{link-en|噬血細胞综合癥|hemophagocytic lymphohistiocytosis}}，一種罕見的致死性幼年期常染色體隱性遺傳病<ref name="entrez"/>。

==相互作用==
數據表明，穿孔素可與{{link-en|鈣網蛋白|calreticulin}}發生[[蛋白質交互作用|蛋白質交互作用]]<ref name="pmid9671507">{{cite journal |author= Andrin C, Pinkoski MJ, Burns K, ''et al.'' |title= Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules |journal= Biochemistry |volume= 37 |issue= 29 |pages= 10386–94 |date=July 1998 |pmid= 9671507 |doi= 10.1021/bi980595z }}</ref>。

==參見==
*{{link-en|顆粒酶|Granzyme}}
*[[防禦素|防禦素]]

==參考==
{{Reflist}}

==拓展閱讀==
{{refbegin |2}}
*{{cite journal |author=Trapani JA |title=Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B |journal=Australian and New Zealand journal of medicine |volume=25 |issue= 6 |pages= 793–9 |year= 1996 |pmid= 8770355 |doi= 10.1111/j.1445-5994.1995.tb02883.x}}
*{{cite journal |author=Peitsch MC, Amiguet P, Guy R, ''et al.'' |title=Localization and [[molecular_modelling|molecular modelling]] of the membrane-inserted domain of the ninth component of human complement and perforin |journal=Mol. Immunol. |volume=27 |issue= 7 |pages= 589–602 |year= 1990 |pmid= 2395434| doi=10.1016/0161-5890(90)90001-G}}
*{{cite journal |author=Young JD, Hengartner H, Podack ER, Cohn ZA |title=Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity |journal=Cell |volume=44 |issue= 6 |pages= 849–59 |year= 1986 |pmid= 2420467| doi=10.1016/0092-8674(86)90007-3}}
*{{cite journal |author=Young JD, Cohn ZA, Podack ER |title=The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities |journal=Science |volume=233 |issue= 4760 |pages= 184–90 |year= 1986 |pmid= 2425429 |doi=10.1126/science.2425429 }}
*{{cite journal |author=Lichtenheld MG, Podack ER |title=Structure of the human perforin gene. A simple gene organization with interesting potential regulatory sequences |journal=J. Immunol. |volume=143 |issue= 12 |pages= 4267–74 |year= 1990 |pmid= 2480391 |doi= }}
*{{cite journal |author=Shinkai Y, Takio K, Okumura K |title=Homology of perforin to the ninth component of complement (C9) |journal=Nature |volume=334 |issue= 6182 |pages= 525–7 |year= 1988 |pmid= 3261391 |doi= 10.1038/334525a0 }}
*{{cite journal |author=Lichtenheld MG, Olsen KJ, Lu P, ''et al.'' |title=Structure and function of human perforin |journal=Nature |volume=335 |issue= 6189 |pages= 448–51 |year= 1988 |pmid= 3419519 |doi= 10.1038/335448a0 }}
*{{cite journal |author=Goebel WS, Schloemer RH, Brahmi Z |title=Target cell-induced perforin mRNA turnover in NK3.3 cells is mediated by multiple elements within the mRNA coding region |journal=Mol. Immunol. |volume=33 |issue= 4–5 |pages= 341–9 |year= 1996 |pmid= 8676885| doi=10.1016/0161-5890(95)00155-7}}
*{{cite journal |author=Nöske K, Bilzer T, Planz O, Stitz L |title=Virus-Specific CD4+ T Cells Eliminate Borna Disease Virus from the Brain via Induction of Cytotoxic CD8+ T Cells |journal=J. Virol. |volume=72 |issue= 5 |pages= 4387–95 |year= 1998 |pmid= 9557729 |doi= |pmc=109669 }}
*{{cite journal |author=Andrin C, Pinkoski MJ, Burns K, ''et al.'' |title=Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules |journal=Biochemistry |volume=37 |issue= 29 |pages= 10386–94 |year= 1998 |pmid= 9671507 |doi= 10.1021/bi980595z }}
*{{cite journal |author=Yu CR, Ortaldo JR, Curiel RE, ''et al.'' |title=Role of a STAT binding site in the regulation of the human perforin promoter |journal=J. Immunol. |volume=162 |issue= 5 |pages= 2785–90 |year= 1999 |pmid= 10072525 |doi= }}
*{{cite journal |author=Stepp SE, Dufourcq-Lagelouse R, Le Deist F, ''et al.'' |title=Perforin gene defects in familial hemophagocytic lymphohistiocytosis |journal=Science |volume=286 |issue= 5446 |pages= 1957–9 |year= 1999 |pmid= 10583959| doi=10.1126/science.286.5446.1957}}
*{{cite journal |author=Takahashi T, Nieda M, Koezuka Y, ''et al.'' |title=Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells |journal=J. Immunol. |volume=164 |issue= 9 |pages= 4458–64 |year= 2000 |pmid= 10779745 |doi= 10.4049/jimmunol.164.9.4458}}
*{{cite journal |author=Badovinac VP, Tvinnereim AR, Harty JT |title=Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma |journal=Science |volume=290 |issue= 5495 |pages= 1354–8 |year= 2000 |pmid= 11082062| doi=10.1126/science.290.5495.1354}}
*{{cite journal |author=Göransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, ''et al.'' |title=Spectrum of Perforin Gene Mutations in Familial Hemophagocytic Lymphohistiocytosis |journal=Am. J. Hum. Genet. |volume=68 |issue= 3 |pages= 590–7 |year= 2001 |pmid= 11179007 |doi=10.1086/318796 |pmc=1274472 }}
*{{cite journal |author=Clementi R, zur Stadt U, Savoldi G, ''et al.'' |title=Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis |journal=J. Med. Genet. |volume=38 |issue= 9 |pages= 643–6 |year= 2002 |pmid= 11565555 |doi=10.1136/jmg.38.9.643 |pmc=1734943 }}
*{{cite journal |author=Ambach A, Bonnekoh B, Gollnick H |title=Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin but not by methotrexate |journal=Skin Pharmacol. Appl. Skin Physiol. |volume=14 |issue= 5 |pages= 249–60 |year= 2001 |pmid= 11586066| doi=10.1159/000056355}}
{{refend}}

==外部連結==
*{{MeshName|perforin}}
{{Pore-forming toxins}}

[[Category:免疫系統|Category:免疫系統]]
[[Category:人类蛋白质|Category:人类蛋白质]]